Probiota Americas

Collaboration among stakeholders needed for probiotics research to move forward, experts say

By Hank Schultz

- Last updated on GMT

Related tags science Probiotic

The immediate future of the probiotics space is clouded by regulatory uncertainty but is buoyed by new science and technology, speakers at the recent Probiota Americas event said.

On the uncertainty side, presenters at the event, hosted by NutraIngredients-USA, said that FDA’s guidance on Investigational New Drugs continues to be a source of difficulty. Without a definition of what a “healthy” gut is, how can companies move forward in seeking to show a benefit for their probiotics without triggering the need for an IND filing and all the complications that come with that?  Up to now, the field has tiptoed around the issue, designed studies nipping at the edges of the problem that seek to advance the scientific base without setting of an IND tripwire. It’s time for that confusing process to end, said Dr Susan Mitmesser, PhD, director of nutrition research for supplement manufacturer NBTY. She called for collaboration among all the stakeholders, including regulators, academics and manufacturers, to find a clearer, more rational path forward.

“My hope for the future is that everybody can leave their preconceived notions at the door, come to the table and have open, collaborative discussions, discussions that lead to more robust products,”​ Mitmesser said.

Good news on science front

Despite the regulatory difficulties, researchers have been moving forward in the realm of pure science. Dr David Sela, PhD,  an assistant professor in food science at the University of Massachusetts Amherst, said new technologies that have come online in recent years have allowed researchers to get a better handle on the individual organisms’ internal mechanics.

“We have had a lot of technology that has come online in just the last ten years that has been really enabling,”​ he said. “We are able to ask questions to really understand what’s going on with the bugs’ physiology and how that is affecting human health.”

Dr Emeran Mayer, MD, director of the  Oppenheimer Family Center for Neurobiology of Stress at UCLA, called for more high quality, large scale studies to validate earlier research that shows that probiotic organisms do indeed have a physiological effect in the human body.

“I think the best parameter to measure is the brain,” ​he said.  

But Mayer cautioned that the field is at a bit of a crossroads. Without a new raft of such high quality studies, the field could slip backwards and start resting on the laurels of earlier studies that, while promising, don’t offer sufficient scientific underpinning.

“Without those studies I think this field could kind of deteriorate into kind of a pseudoscience, with a totally commercially driven agenda, and I think that would be a shame if that happened,”​ he said.

Related news

Related products

show more

A Groundbreaking Prebiotic

A Groundbreaking Prebiotic

Content provided by ADM | 12-Mar-2024 | Infographic

PreforPro® is a clinically studied prebiotic that supports the growth of select beneficial bacteria in the gut by utilizing phage technology.

Go Beyond the Ordinary: Cognitive Health-BacoMind

Go Beyond the Ordinary: Cognitive Health-BacoMind

Content provided by Natural Remedies Private Limited | 27-Feb-2024 | White Paper

Experience the potency of BacoMind®, the #1 branded bacopa with 9 key bioactives for unparalleled cognitive support.

Stay one step ahead in the collagen market

Stay one step ahead in the collagen market

Content provided by Bioiberica | 26-Feb-2024 | White Paper

It's no secret that interest in collagen is at an all-time high – especially for joint health. This presents a real opportunity for manufacturers...

Nootropics Report 2.0: Brain Health Insights

Nootropics Report 2.0: Brain Health Insights

Content provided by dsm-firmenich | 22-Feb-2024 | Insight Guide

The brain health market is constantly growing and evolving, with more consumers looking for innovative ways to support total mind and body wellness.

Related suppliers

1 comment

Commercially driven Agenda is a good Thing!

Posted by Gerry Morrison, Active D'Lites,

Science and Companies, working together, will drive both innovation and solutions to hep people. Synbiotics will be the key for maximizing probiotics vast potentials. Function foods will play a major role in allowing consumers options for better health and wellness providing they are spot on for taste (trial).

Report abuse

Follow us

Products

View more

Webinars